News
Eisai Co. and Biogen Inc. received US regulatory approval for a new self-injected form of their Alzheimer’s drug Leqembi, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback